Rare reports of necrotising fasciitis of the perineum (Fournier’s fasciitis) led the Food and Drug Administration (FDA) to request the addition of a warning to the SGLT2 inhibitor prescribing instructions; whether these very rare but serious infections are causally related to SGLT2 inhibitor therapy remains unclear [14]. This evidence concerns the gene SLC5A2 and infection.